WGS vs. TALK, INNV, PNTG, DCGO, SHCR, PIII, USPH, ZJYL, LFMD, and ANL
Should you be buying GeneDx stock or one of its competitors? The main competitors of GeneDx include Talkspace (TALK), InnovAge (INNV), The Pennant Group (PNTG), DocGo (DCGO), Sharecare (SHCR), P3 Health Partners (PIII), U.S. Physical Therapy (USPH), Jin Medical International (ZJYL), LifeMD (LFMD), and Adlai Nortye (ANL). These companies are all part of the "medical" sector.
Talkspace (NASDAQ:TALK) and GeneDx (NASDAQ:WGS) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, institutional ownership, valuation, earnings, analyst recommendations, media sentiment, dividends, profitability and community ranking.
Talkspace has higher earnings, but lower revenue than GeneDx. Talkspace is trading at a lower price-to-earnings ratio than GeneDx, indicating that it is currently the more affordable of the two stocks.
Talkspace presently has a consensus target price of $3.00, suggesting a potential upside of 4.17%. GeneDx has a consensus target price of $18.00, suggesting a potential downside of 17.28%. Given GeneDx's higher probable upside, equities analysts clearly believe Talkspace is more favorable than GeneDx.
Talkspace has a net margin of -7.33% compared to Talkspace's net margin of -60.86%. GeneDx's return on equity of -10.00% beat Talkspace's return on equity.
GeneDx received 3 more outperform votes than Talkspace when rated by MarketBeat users. Likewise, 42.86% of users gave GeneDx an outperform vote while only 0.00% of users gave Talkspace an outperform vote.
Talkspace has a beta of 1.29, suggesting that its share price is 29% more volatile than the S&P 500. Comparatively, GeneDx has a beta of 2.17, suggesting that its share price is 117% more volatile than the S&P 500.
57.4% of Talkspace shares are owned by institutional investors. Comparatively, 61.7% of GeneDx shares are owned by institutional investors. 18.4% of Talkspace shares are owned by insiders. Comparatively, 28.1% of GeneDx shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
In the previous week, Talkspace had 12 more articles in the media than GeneDx. MarketBeat recorded 15 mentions for Talkspace and 3 mentions for GeneDx. GeneDx's average media sentiment score of 0.85 beat Talkspace's score of 0.73 indicating that Talkspace is being referred to more favorably in the media.
Summary
Talkspace and GeneDx tied by winning 9 of the 18 factors compared between the two stocks.
Get GeneDx News Delivered to You Automatically
Sign up to receive the latest news and ratings for WGS and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding WGS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
